On October 12, 2022 AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, reported that chief medical officer Dr. Robert O. Dillman will deliver a keynote at the second annual Vaccines Summit 2022 meeting (Press release, AIVITA Biomedical, OCT 12, 2022, View Source [SID1234621949]). The meeting is taking place in person, October 11-13, in the Washington, D.C., area. Dr. Dillman’s speaking details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

In his keynote, Dr. Dillman will share findings from trials of AIVITA’s personalized vaccine platform for cancer and COVID-19, highlighting the feasibility of the approach, lack of significant toxicity, and observed benefits that support the potential of the company’s strategy for personalized dendritic cell therapies.